XFOR - X4 Pharmaceuticals GAAP EPS of -$0.26 May, 07 2024 06:05 AM X4 Pharmaceuticals Inc. 2024-05-07 06:05:57 ET More on X4 Pharmaceuticals X4 Pharmaceuticals: FDA Approval For WHIM Warrants Further Upside X4 Pharmaceuticals: PDUFA Excitement Ahead X4 gets FDA approval for Xolremdi for WHIM syndrome X4 Pharmaceuticals GAAP EPS of -$0.10 beats by $0.05 For further details see: X4 Pharmaceuticals GAAP EPS of -$0.26